# Guangzhou Yue Min Investment

> Guangzhou Yue Min Investment is a VC fund backing Health Care and Biotechnology. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Feb 2022
- Lead investor: 0%
- Last updated: Aug 2026

Guangzhou Yue Min Investment is an investment firm

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Software | 1 | 33% |
| Medical Device | 1 | 33% |
| Pharmaceutical | 1 | 33% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Centrymed | Centrymed focuses on the field of tumor treatment, and its self-developed dual-antibody platform. The company's independent intellectual property rights have solved the problems of drug drugability and toxic and side effects of antibody drugs. |  | Series A | Feb 09, 2022 | http://www.centrymed.com/ |
| Iluvatar CoreX | Iluvatar CoreX is a leading developer of high-performance computing solutions including System-on-a-Chip (SoC) chipset and its proprietary software platform. The company was founded in December 2015 by a group of world-class software and semiconductor experts from Silicon Valley and China which have been working together for more than two decadesin the field of AI at companies like Oracle, AMD/ATI and Fujitsu.Iluvatar has assembled a group of experts in system software, computing middleware, algorithms, parallel processing, GPU, AI, and IC design to develop end-to-end high-performance processing solutions in-house. Iluvatar solution addresses the limitations on computing power needs for AI applications by creatively exploiting the advantages of ultra-large-scale parallel computing architecture, with its general-purpose, standard, and high-performance cloud computing SoC solution (GP-GPU). Iluvatar solution is already proven. For the last 3 years, the company has been shipping its new generation of data processing software technology (soft silicon) named SkyDiscovery. | $185.6M | Series C | Mar 01, 2021 | http://www.iluvatar.com.cn |
| Apollomics | Apollomics, Inc. is an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer. The company’s existing pipeline consists of several development-stage assets, including novel, humanizedmonoclonal antibodies that restore the body’s immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. | $100M | Series B | Jan 08, 2019 | https://www.apollomicsinc.com/ |

3 of 3 investments shown.

## Co-investors
- [Anji Maisheng](https://shizune.co/investors/profile/anji-maisheng) — VC Fund, 1 deal together
- [Betta Pharmaceuticals](https://shizune.co/investors/profile/betta-pharmaceuticals) — VC Fund, 1 deal together
- [Binjiang District Government Fund Hang Gao Investment](https://shizune.co/investors/profile/binjiang-district-government-fund-hang-gao-investment) — VC Fund, 1 deal together
- [Cedarlake Capital](https://shizune.co/investors/profile/cedarlake-capital) — VC Fund, 1 deal together
- [Centurium Capital](https://shizune.co/investors/profile/centurium-capital) — VC Fund, 1 deal together
- Chenghe Venture Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Guangzhou Yue Min Investment invest in?

Guangzhou Yue Min Investment invests primarily in Health Care, Biotechnology and Software startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Guangzhou Yue Min Investment last invest?

The most recent investment recorded for Guangzhou Yue Min Investment closed in Feb 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co